Regenerative Medicine

An autologous blood-derived treatment where concentrated platelets and growth factors are injected to accelerate tissue healing, reduce joint pain, restore hair growth, and rejuvenate skin. One of the most widely adopted regenerative treatments globally.

Injection of dextrose (sugar water) solution into damaged joints, tendons, and ligaments to stimulate the body's natural healing response. Decades of use in sports medicine with growing RCT evidence for knee and low back pain.

Autologous regenerative therapy using concentrated stem cells and growth factors extracted from the patient's own bone marrow (typically from the iliac crest). BMAC contains mesenchymal stem cells, growth factors, and anti-inflammatory cytokines for joint and tissue repair.

Regenerative treatment using processed amniotic membrane or fluid containing growth factors, cytokines, and hyaluronic acid. Applied for joint pain, wound healing, and tissue regeneration. Less controversial than embryonic stem cells as tissue comes from consenting donors post-delivery.

Regenerative medicine using stem cells (MSCs) for joint repair, anti-aging, and tissue regeneration. Rapidly advancing field with promising but variable results.

Concentrated injection of alpha-2-macroglobulin, a naturally occurring protease inhibitor in blood that blocks cartilage-destroying enzymes. Extracted from patient's own blood and injected into damaged joints. Newer regenerative approach for osteoarthritis and cartilage preservation.

Combines prolotherapy (dextrose/nutrient injection) with medical-grade ozone gas injection into joints and soft tissues. The ozone stimulates oxygen utilization and cellular repair while the prolotherapy solution promotes healing. Used for chronic pain, joint degeneration, and sports injuries.

Cell-free regenerative treatment using exosomes (nano-vesicles) derived from mesenchymal stem cells. Contains growth factors and miRNAs that promote tissue repair. Exciting preclinical science but limited clinical validation.